Cara Therapeutics Inc (CARA)
0.3299
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
0.3156
-0.01
(-4.33%)
After-Hours: 20:00
Cara Therapeutics Free Cash Flow (Quarterly): -12.65M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -12.65M |
| March 31, 2024 | -31.29M |
| December 31, 2023 | -19.42M |
| September 30, 2023 | -19.97M |
| June 30, 2023 | -20.44M |
| March 31, 2023 | -34.62M |
| December 31, 2022 | -23.51M |
| September 30, 2022 | -25.19M |
| June 30, 2022 | -4.503M |
| March 31, 2022 | -25.57M |
| December 31, 2021 | -1.245M |
| September 30, 2021 | -14.12M |
| June 30, 2021 | -21.00M |
| March 31, 2021 | -23.72M |
| December 31, 2020 | 81.92M |
| September 30, 2020 | -21.80M |
| June 30, 2020 | -27.65M |
| March 31, 2020 | -38.30M |
| December 31, 2019 | -31.17M |
| September 30, 2019 | -25.64M |
| June 30, 2019 | -24.90M |
| March 31, 2019 | -27.54M |
| December 31, 2018 | -24.38M |
| Date | Value |
|---|---|
| September 30, 2018 | -20.52M |
| June 30, 2018 | 41.00M |
| March 31, 2018 | -18.47M |
| December 31, 2017 | -11.41M |
| September 30, 2017 | -9.879M |
| June 30, 2017 | -11.95M |
| March 31, 2017 | -21.64M |
| December 31, 2016 | -13.26M |
| September 30, 2016 | -13.39M |
| June 30, 2016 | -11.61M |
| March 31, 2016 | -9.841M |
| December 31, 2015 | -4.175M |
| September 30, 2015 | -7.816M |
| June 30, 2015 | -4.26M |
| March 31, 2015 | -5.247M |
| December 31, 2014 | -5.839M |
| September 30, 2014 | -4.509M |
| June 30, 2014 | -4.245M |
| March 31, 2014 | -3.091M |
| December 31, 2013 | -5.065M |
| September 30, 2013 | -3.445M |
| June 30, 2013 | 13.15M |
| March 31, 2013 | -1.819M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-38.30M
Minimum
Mar 2020
81.92M
Maximum
Dec 2020
-16.54M
Average
-21.80M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.917M |
| Alaunos Therapeutics Inc | -1.681M |
| Oragenics Inc | -1.544M |
| Cocrystal Pharma Inc | -3.699M |
| Citius Pharmaceuticals Inc | -8.367M |